{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:59:40Z","timestamp":1792047580752,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T00:00:00Z","timestamp":1544659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001755","name":"Mesothelioma Applied Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Italian Association for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009888","name":"Tuscany Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ebiomedicine.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ebiom.2018.12.025","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T17:20:41Z","timestamp":1545326441000},"page":"215-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma"],"prefix":"10.1016","volume":"39","author":[{"given":"Rocco","family":"Sciarrillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wojtuszkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Btissame","family":"El Hassouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccola","family":"Funel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gandellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1043-7452","authenticated-orcid":false,"given":"Tonny","family":"Lagerweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Buonamici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Blijlevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline A.","family":"Zeeuw van der Laan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Zaffaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Deraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Kusamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"W\u00fcrdinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godefridus J.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla F.M.","family":"Molthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertjan J.L.","family":"Kaspers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9150-8026","authenticated-orcid":false,"given":"Jacqueline","family":"Cloos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7565-7504","authenticated-orcid":false,"given":"Elisa","family":"Giovannetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ebiom.2018.12.025_bb0005","doi-asserted-by":"crossref","first-page":"915","DOI":"10.21037\/jgo.2017.08.01","article-title":"Clinical presentation, diagnosis, classification and management of peritoneal mesothelioma: a review","volume":"8","author":"Garc\u00eda-Fadrique","year":"2017","journal-title":"J Gastrointest Oncol"},{"issue":"8","key":"10.1016\/j.ebiom.2018.12.025_bb0010","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1245\/s10434-018-6337-5","article-title":"Current management and future opportunities for peritoneal metastases: peritoneal mesothelioma","volume":"25","author":"Alexander","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ebiom.2018.12.025_bb0015","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/02656736.2018.1434902","article-title":"Outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma and predictors of survival","volume":"34","author":"Gilani","year":"2018","journal-title":"Int. J. Hyperthermia"},{"issue":"2","key":"10.1016\/j.ebiom.2018.12.025_bb0020","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/modpathol.2016.188","article-title":"Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X","volume":"30","author":"Joseph","year":"2017","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.ebiom.2018.12.025_bb0025","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1136\/jclinpath-2014-202465","article-title":"Comparison of genomic abnormality in malignant mesothelioma by the site of origin","volume":"67","author":"Takeda","year":"2014","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ebiom.2018.12.025_bb0030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.humpath.2016.04.015","article-title":"Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization array","volume":"55","author":"Chirac","year":"2016","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.ebiom.2018.12.025_bb0035","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat Genet"},{"issue":"19","key":"10.1016\/j.ebiom.2018.12.025_bb0040","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1038\/onc.2015.318","article-title":"Aberrant RNA splicing in cancer; Expression changes and driver mutations of splicing factor genes","volume":"35","author":"Sveen","year":"2016","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.ebiom.2018.12.025_bb0045","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrc.2016.51","article-title":"RNA splicing factors as oncoproteins and tumour suppressors","volume":"16","author":"Dvinge","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.ebiom.2018.12.025_bb0050","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1517\/17425255.2015.993316","article-title":"Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance","volume":"11","author":"Wojtuszkiewicz","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"10.1016\/j.ebiom.2018.12.025_bb0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.molmed.2015.11.005","article-title":"Small Molecule Modulators of pre-mRNA Splicing in Cancer Therapy","volume":"22","author":"Salton","year":"2016","journal-title":"Trends Mol Med"},{"issue":"4","key":"10.1016\/j.ebiom.2018.12.025_bb0060","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1074\/jbc.M113.515536","article-title":"Coherence between cellular responses and in vitro splicing inhibition for the anti-tumor drug pladienolide b and its analogs","volume":"289","author":"Effenberger","year":"2014","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.ebiom.2018.12.025_bb0065","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrd3823","article-title":"The spliceosome as a target of novel antitumour drugs","volume":"11","author":"Bonnal","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"10.1016\/j.ebiom.2018.12.025_bb0070","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nchembio.2007.16","article-title":"Splicing factor SF3b as a target of the antitumor natural product pladienolide","volume":"3","author":"Kotake","year":"2007","journal-title":"Nat Chem Biol"},{"issue":"22","key":"10.1016\/j.ebiom.2018.12.025_bb0075","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1158\/1078-0432.CCR-13-0485","article-title":"Phase I pharmacokinetic and pharmacodynamic study of the first-in-class spliceosome inhibitor E7107 in patients with advanced solid tumors","volume":"19","author":"Eskens","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.ebiom.2018.12.025_bb0080","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s10637-013-0046-5","article-title":"A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors","volume":"32","author":"Hong","year":"2014","journal-title":"Invest New Drugs"},{"issue":"4","key":"10.1016\/j.ebiom.2018.12.025_bb0085","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nm.4493","article-title":"H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers","volume":"24","author":"Seiler","year":"2018","journal-title":"Nat Med"},{"issue":"15","key":"10.1016\/j.ebiom.2018.12.025_bb0090","doi-asserted-by":"crossref","first-page":"13119","DOI":"10.18632\/oncotarget.3761","article-title":"Anti-tumor activity of selective inhibitors of XPO1\/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin","volume":"6","author":"De Cesare","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ebiom.2018.12.025_bb0095","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nmeth.1177","article-title":"A secreted luciferase for ex vivo monitoring of in vivo processes","volume":"5","author":"Wurdinger","year":"2008","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.ebiom.2018.12.025_bb0100","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/srep01046","article-title":"Functional multiplex reporter assay using tagged Gaussia luciferase","volume":"3","author":"van Rijn","year":"2013","journal-title":"Sci Rep"},{"issue":"22","key":"10.1016\/j.ebiom.2018.12.025_bb0105","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.1158\/0008-5472.CAN-13-0837","article-title":"Crizotinib inhibits metabolic inactivation of gemcitabine in c-Met-driven pancreatic carcinoma","volume":"73","author":"Avan","year":"2013","journal-title":"Cancer Res"},{"issue":"118","key":"10.1016\/j.ebiom.2018.12.025_bb0110","first-page":"e54714","article-title":"Using RNA-sequencing to detect novel splice variants related to drug resistance in in vitro cancer models","volume":"9","author":"Sciarrillo","year":"2016","journal-title":"J Vis Exp"},{"issue":"13","key":"10.1016\/j.ebiom.2018.12.025_bb0115","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/bioinformatics\/btn224","article-title":"Lumi: a pipeline for processing Illumina microarray","volume":"24","author":"Du","year":"2008","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.ebiom.2018.12.025_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"Smyth","year":"2004","journal-title":"Stat Appl Genet Mol Biol"},{"issue":"Suppl. 16","key":"10.1016\/j.ebiom.2018.12.025_bb0125","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1186\/1471-2105-13-S16-S12","article-title":"1D and 2D annotation enrichment: a statistical method integrating quantitative proteomics with complementary high-throughput data","volume":"13","author":"Cox","year":"2012","journal-title":"BMC Bioinformatics"},{"issue":"W1","key":"10.1016\/j.ebiom.2018.12.025_bb0130","doi-asserted-by":"crossref","first-page":"W83","DOI":"10.1093\/nar\/gkw199","article-title":"G:Profiler-a web server for functional interpretation of gene lists (2016 update)","volume":"44","author":"Reimand","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2018.12.025_bb0135","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1186\/ar4191","article-title":"Evaluation of the novel folate receptor ligand [18 F] fluoro-PEG-folate for macrophage targeting in a rat model of arthritis","volume":"15","author":"Gent","year":"2013","journal-title":"Arthr Res Ther"},{"issue":"13","key":"10.1016\/j.ebiom.2018.12.025_bb0140","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1245\/s10434-015-4498-z","article-title":"Immunohistochemical Evaluation of Minichromosome Maintenance Protein 7 (MCM7), Topoisomerase II, and Ki-67 in Diffuse Malignant Peritoneal Mesothelioma patients using Tissue Microarray","volume":"22","author":"Deraco","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ebiom.2018.12.025_bb0145","first-page":"453","article-title":"Survivin is highly expressed and promotes cell survival in malignant peritoneal mesothelioma","volume":"29","author":"Zaffaroni","year":"2007","journal-title":"Cell Oncol"},{"issue":"51","key":"10.1016\/j.ebiom.2018.12.025_bb0150","doi-asserted-by":"crossref","first-page":"E5593","DOI":"10.1073\/pnas.1419161111","article-title":"rMATS: Robust and flexible detection of differential alternative splicing from replicate RNA-Seq data","volume":"111","author":"Shen","year":"2014","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"10.1016\/j.ebiom.2018.12.025_bb0155","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbcan.2014.01.008","article-title":"The role of key genes and pathways involved in the tumorigenesis of Malignant Mesothelioma","volume":"1845","author":"De Assis","year":"2014","journal-title":"Biochim Biophys Acta - Rev Cancer"},{"key":"10.1016\/j.ebiom.2018.12.025_bb0160","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1038\/srep06098","article-title":"Regulation of HPV16 E6 and MCL1 by SF3B1 inhibitor in head and neck cancer cells","volume":"4","author":"Gao","year":"2014","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2018.12.025_bb0165","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1083\/jcb.201510032","article-title":"Defective control of pre-messenger RNA splicing in human disease","volume":"212","author":"Chabot","year":"2016","journal-title":"J Cell Biol"},{"issue":"6","key":"10.1016\/j.ebiom.2018.12.025_bb0170","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.molcel.2005.10.026","article-title":"Cell motility is controlled by SF2\/ASF through alternative splicing of the Ron protooncogene","volume":"20","author":"Ghigna","year":"2005","journal-title":"Mol Cell"},{"issue":"15","key":"10.1016\/j.ebiom.2018.12.025_bb0175","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","article-title":"Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts","volume":"365","author":"Papaemmanuil","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ebiom.2018.12.025_bb0180","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","article-title":"Integrative analysis identifies four molecular and clinical subsets in uveal melanoma","volume":"32","author":"Robertson","year":"2017","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.ebiom.2018.12.025_bb0185","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.celrep.2015.09.053","article-title":"Cancer-associated SF3B1 hotspot mutations induce cryptic 3\u2019 splice site selection through use of a different branch point","volume":"13","author":"Darman","year":"2015","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2018.12.025_bb0190","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/14728222.2018.1417390","article-title":"Exploiting differential RNA splicing patterns: a potential new group of therapeutic targets in cancer","volume":"22","author":"Jyotsana","year":"2018","journal-title":"Expert Opin Ther Target"},{"issue":"3\u20134","key":"10.1016\/j.ebiom.2018.12.025_bb0195","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1101\/gad.311043.117","article-title":"The cryo-EM structure of the SF3b spliceosome complex bound to a splicing modulator reveals a pre-mRNA substrate competitive mechanism of action","volume":"32","author":"Finci","year":"2018","journal-title":"Genes Dev"},{"issue":"2","key":"10.1016\/j.ebiom.2018.12.025_bb0200","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.molcel.2018.03.011","article-title":"Structural basis of splicing modulation by antitumor macrolide compounds","volume":"70","author":"Cretu","year":"2018","journal-title":"Mol Cell"},{"key":"10.1016\/j.ebiom.2018.12.025_bb0205","doi-asserted-by":"crossref","first-page":"9041","DOI":"10.1038\/sj.onc.1207114","article-title":"Heat-shock proteins as regulators of apoptosis","volume":"22","author":"Takayama","year":"2003","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.ebiom.2018.12.025_bb0210","first-page":"3080","article-title":"Gene expression profiling of malignant mesothelioma","volume":"9","author":"Kaiser","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2018.12.025_bb0215","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.lungcan.2009.03.016","article-title":"Malignant pleural mesothelioma: Genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets","volume":"67","author":"R\u00f8e","year":"2010","journal-title":"Lung Cancer"},{"issue":"46","key":"10.1016\/j.ebiom.2018.12.025_bb0220","doi-asserted-by":"crossref","first-page":"75503","DOI":"10.18632\/oncotarget.12262","article-title":"Epithelioid peritoneal mesothelioma: a hybrid phenotype within a mesenchymal-epithelial\/epithelial-mesenchymal transition framework","volume":"7","author":"Bozzi","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.ebiom.2018.12.025_bb0225","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1128\/MCB.16.10.5518","article-title":"A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype","volume":"16","author":"Collesi","year":"1996","journal-title":"Mol Cell Biol"},{"issue":"15","key":"10.1016\/j.ebiom.2018.12.025_bb0230","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1007\/s00018-012-0931-7","article-title":"Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT)","volume":"69","author":"Biamonti","year":"2012","journal-title":"Cell Mol Life Sci"},{"issue":"7569","key":"10.1016\/j.ebiom.2018.12.025_bb0235","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature14985","article-title":"The spliceosome is a therapeutic vulnerability in MYC-driven cancer","volume":"525","author":"Hsu","year":"2015","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ebiom.2018.12.025_bb0240","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/JTO.0000000000000202","article-title":"Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma","volume":"9","author":"Riquelme","year":"2014","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1016\/j.ebiom.2018.12.025_bb0245","doi-asserted-by":"crossref","first-page":"e0172209","DOI":"10.1371\/journal.pone.0172209","article-title":"Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status","volume":"12","author":"Suda","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2018.12.025_bb0250","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biocel.2017.04.006","article-title":"Chemotherapy induces alternative transcription and splicing: Facts and hopes for cancer treatment","volume":"91","author":"Lambert","year":"2017","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"10.1016\/j.ebiom.2018.12.025_bb0255","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1158\/1078-0432.CCR-16-0131","article-title":"Molecular pathways: Understanding and targeting mutant spliceosomal proteins","volume":"23","author":"Yoshimi","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ebiom.2018.12.025_bb0260","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.gde.2017.10.010","article-title":"Targeting splicing abnormalities in cancer","volume":"48","author":"Agrawal","year":"2018","journal-title":"Curr Opin Genet Dev"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418306029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418306029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T03:37:15Z","timestamp":1565235435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396418306029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":52,"alternative-id":["S2352396418306029"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.12.025","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}